532
Views
26
CrossRef citations to date
0
Altmetric
Drug Evaluations

The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment

, MD, , MD, , MD, , , MD, , MD & , MD PhD show all
Pages 1361-1369 | Published online: 27 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Elisa Marabotto, Sebastiano Ziola, Vincenzo Savarino, Edoardo Giovanni Giannini, Manuele Furnari, Giorgia Bodini, Fabiana Zingone, Matteo Ghisa, Brigida Barberio, Patrizia Zentilin & Edoardo Savarino. (2020) Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data. Clinical and Experimental Gastroenterology 13, pages 99-104.
Read now
Irene Martinucci, Corrado Blandizzi, Giorgia Bodini, Elisa Marabotto, Vincenzo Savarino, Santino Marchi, Nicola de Bortoli & Edoardo Savarino. (2017) Vonoprazan fumarate for the management of acid-related diseases. Expert Opinion on Pharmacotherapy 18:11, pages 1145-1152.
Read now
Hongyun Wang, Ning Ou, Liwei Lang, Ruihua Shi, Pei Hu & Ji Jiang. (2016) Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses. Xenobiotica 46:12, pages 1133-1141.
Read now
Edoardo Savarino, Irene Martinucci, Manuele Furnari, Chiara Romana, Gaia Pellegatta, Alessandro Moscatelli, Giorgia Bodini, Elisa Marabotto, Vincenzo Savarino, Nicola de Bortoli & Corrado Blandizzi. (2016) Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations. Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1333-1341.
Read now
Edoardo Savarino, Andrea Ottonello, Irene Martinucci, Pietro Dulbecco & Vincenzo Savarino. (2016) Ilaprazole for the treatment of gastro-esophageal reflux. Expert Opinion on Pharmacotherapy 17:15, pages 2107-2113.
Read now

Articles from other publishers (21)

Jianping Cheng, Chanjuan Fan, Kun Huang, Lili Zhai, Hui Wang, Dongling Xie, Yong Cai, Zhen Li, Qixuan Bai, Pan Wang & Haiou Ding. (2023) Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial. Frontiers in Pharmacology 14.
Crossref
Jonathan Leis, Chi-Hao Luan, James E. Audia, Sara F. Dunne & Carissa M. Heath. (2021) Ilaprazole and Other Novel Prazole-Based Compounds That Bind Tsg101 Inhibit Viral Budding of Herpes Simplex Virus 1 and 2 and Human Immunodeficiency Virus from Cells. Journal of Virology 95:11.
Crossref
He-Jian Zhang, Xue-Hui Zhang, Jie Liu, Lu-Ning Sun, Yi-Wen Shen, Chen Zhou, Hong-Wen Zhang, Li-Jun Xie, Juan Chen, Yun Liu & Yong-Qing Wang. (2020) Effects of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of proton pump inhibitors. Pharmacological Research 152, pages 104606.
Crossref
Seung Woo Lee, Sung Jin Moon, Sae Hee Kim, Sung Hee Jung, Kyung Ho Song, Sun Moon Kim, Jae Kyu Sung & Dong Soo Lee. (2020) The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori. Medicine 99:38, pages e22137.
Crossref
Hongyun Wang, Feng Shao, Xuemei Liu, Wen Xu, Ning Ou, Xianghong Qin, Fang Liu, Xuemei Hou, Haitang Hu & Ji Jiang. (2019) Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control. British Journal of Clinical Pharmacology 85:11, pages 2547-2558.
Crossref
S. Sobrino-Cossío, O. Teramoto-Matsubara, G. Mateos-Pérez, J.M. Abdo-Francis, J. Tawil, C. Olguín-Ramírez, A. Orozco-Gamiz & E.S. Galvis-García. (2019) In search of the grail: A race for acid suppression. Revista de Gastroenterología de México (English Edition) 84:3, pages 344-356.
Crossref
S. Sobrino-Cossío, O. Teramoto-Matsubara, G. Mateos-Pérez, J.M. Abdo-Francis, J. Tawil, C. Olguín-Ramírez, A. Orozco-Gamiz & E.S. Galvis-García. (2019) La búsqueda del Grial: una carrera por la supresión ácida. Revista de Gastroenterología de México 84:3, pages 344-356.
Crossref
Chang Seok Bang, Woon Geon Shin, Seung In Seo, Min Ho Choi, Hyun Joo Jang, Se Woo Park, Sea Hyub Kae, Young Joo Yang, Suk Pyo Shin, Gwang Ho Baik & Hak Yang Kim. (2018) Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study. Surgical Endoscopy 33:5, pages 1376-1385.
Crossref
Richard H. Hunt & Carmelo Scarpignato. (2018) Potent Acid Suppression with PPIs and P-CABs: What’s New?. Current Treatment Options in Gastroenterology 16:4, pages 570-590.
Crossref
Jie Pu, Fen Wang, Wei Tang & Mingshe Zhu. (2018) Biotransformation of Ilaprazole in Human Liver Microsomes and Human: Role of CYP3A4 in Ilaprazole Clearance and Drug-Drug Interaction. Drug Metabolism and Disposition 46:10, pages 1453-1461.
Crossref
Byung Hak Jin, Byung Won Yoo, Jungsin Park, Jung Hye Kim, Jun Yeon Lee, Jae Soo Shin & Min Soo Park. (2018) Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study. European Journal of Clinical Pharmacology 74:9, pages 1149-1157.
Crossref
In Ji SongHyun Ki KimNa Keum LeeSang Kil Lee. (2018) Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis. Yonsei Medical Journal 59:8, pages 951.
Crossref
Duowu Zou & Khean‐Lee Goh. (2017) East Asian perspective on the interaction between proton pump inhibitors and clopidogrel. Journal of Gastroenterology and Hepatology 32:6, pages 1152-1159.
Crossref
Arun Karyampudi, Uday C Ghoshal, Rajan Singh, Abhai Verma, Asha Misra & Vivek A Saraswat. (2017) Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease. Journal of Neurogastroenterology and Motility 23:2, pages 208-217.
Crossref
Hyo Jun Ahn, Dong Pil Kim, Myeong Su Chu, Hyeon Jeong Yun, Seok-Hwan Kim, Seung Woo Lee & Dong Soo Lee. (2017) Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections . Gastroenterology Research and Practice 2017, pages 1-6.
Crossref
Vincenzo Savarino, Pietro Dulbecco, Nicola de Bortoli, Andrea Ottonello & Edoardo Savarino. (2017) The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal. European Journal of Internal Medicine 37, pages 19-24.
Crossref
Jeong Hwan Kim. (2016) Pharmacologic Management of Nonvariceal Upper Gastrointestinal Bleeding. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 16:4, pages 189.
Crossref
WonGun Kwack, YunJeong Lim, ChiYeon Lim & David Y. Graham. (2016) High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea . Gastroenterology Research and Practice 2016, pages 1-7.
Crossref
Xiao-Min Liao. (2015) Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection . World Journal of Gastroenterology 21:20, pages 6310.
Crossref
Gang Yu, Xin-Qiang Lu, Rui-Bin Su, Ze-Hui Gong, He-Zhi Xie, Hai-Tang Hu & Xue-Mei Hou. (2014) Intravenous Ilaprazole Is More Potent than Oral Ilaprazole Against Gastric Lesions in Rats. Digestive Diseases and Sciences 59:10, pages 2417-2422.
Crossref
Jung Hwan Oh. (2014) Pharmacological Therapy of Peptic Ulcer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 14:1, pages 13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.